LCM
EW icon

Logan Capital Management’s Edwards Lifesciences EW Stock Holding History

Logan Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,621
Closed -$290K – 521
2026
Q1 		$290K Buy
+3,621
New +$299K 0.01% 263

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Logan Capital Management's EW Position: Q2 2026 in Review

Logan Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,621 shares worth $328K. The stake represents 0.01% of the portfolio and ranks #262 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in EW as recently as Q4 2025.

Logan Capital Management first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $15.2M in Q2 2013. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Logan Capital Management held 3,621 shares of Edwards Lifesciences worth $328K as of Q2 2026.
  • Edwards Lifesciences was a new Logan Capital Management position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Logan Capital Management's portfolio in Q2 2026, its #262 holding.
  • Logan Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
  • Logan Capital Management's Edwards Lifesciences position peaked at $15.2M in Q2 2013.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.